Sign In
Buy XPH
$56.32
+0.615 (+1.10%)
At Close: Jun 03, 2026
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
07:32am, Thursday, 12'th Jan 2023
Sector ETF report for XPH
Can Health Care Stocks Outperform Again In 2023?
06:09pm, Wednesday, 11'th Jan 2023
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
Amgen to Buy Horizon Therapeutics: ETFs to Bet On
12:48pm, Tuesday, 13'th Dec 2022
Amgen (AMGN) has agreed to buy Horizon Therapeutics PLC (HZNP) for $27.8 billion. This put the spotlight on pharma ETFs, which could be the best way for investors to tap the opportunity arising from t
XPH: U.S. Pharmaceuticals Stocks Are Probably Fairly Valued, Cyclically Unattractive
03:33am, Sunday, 13'th Nov 2022
XPH invests in U.S. pharmaceuticals stocks. The fund is concentrated in 44 holdings.
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
07:32am, Friday, 11'th Nov 2022
Smart Beta ETF report for XPH
Pharma ETFs in Focus Post Q3 Earnings
12:47pm, Wednesday, 09'th Nov 2022
The Q3 earnings picture for the healthcare sector seems solid, with results from companies that have reported so far up 2.1% on 5.8% revenue growth.
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
07:32am, Wednesday, 09'th Nov 2022
Sector ETF report for XPH
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
07:32am, Thursday, 08'th Sep 2022
Smart Beta ETF report for XPH
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
07:31am, Tuesday, 06'th Sep 2022
Sector ETF report for XPH
What The Inflation Reduction Act Means For Drug Prices
01:24am, Friday, 26'th Aug 2022
The recently enacted Inflation Reduction Act looks to rein in prescription drug prices and could impact the pharma industry's long-term financial performance. The legislation caps out-of-pocket costs
Get ready for more merger mania in pharma sector the rest of the year
02:43pm, Tuesday, 09'th Aug 2022
Pfizer Inc.'s PFE, +0.24% $5.4 billion acquisition of Global Blood Therapeutics Inc. GBT, +0.02% is the latest sign that cash-flush drug makers are ready to jump back into dealmaking.
ETF Areas to Win/Lose on Falling Biden's Approval Ratings
02:45pm, Wednesday, 27'th Jul 2022
Biden's approval ratings are falling. These sectors ETFs may gain/lose amid this scenario.
Pharma & Biotech ETFs at One-Month High: Here's Why
09:20am, Friday, 08'th Jul 2022
Pharma and biotech ETFs are in great shape and are trading at a one-month high level.
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
07:48am, Friday, 08'th Jul 2022
Smart Beta ETF report for XPH
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
07:45am, Thursday, 07'th Jul 2022
Sector ETF report for XPH
